H19 and cancer: Upon silencing of the H19 lncRNA in doxorubicin-resistant MCF-7 cells, there was a marked improvement in the sensitivity of cancer cells to chemotherapy agents such as paclitaxel and anthracyclines, accompanied by a significant decrease in the expression levels of MRP4 and MDR1 [65].